Sara Bartolaccini

Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells

E. Stupka, D. Lazarević, L. Naldini, 2017, EMBO molecular medicine.

Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates

A. Annoni, M. Biffi, L. Naldini, 2019, Science Translational Medicine.

Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice

A. Annoni, L. Naldini, M. Roncarolo, 2013, EMBO molecular medicine.

Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells.

L. Naldini, F. Piras, A. Kajaste-Rudnitski, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy

A. Annoni, M. Biffi, J. Lengler, 2017, EMBO molecular medicine.